Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysis.

Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysis.

Item
http://www.wikidata.org/entity/Q44212086
Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer.Time to full publication of studies of anticancer drugs for breast cancer, and the potential for publication bias.Is Higher Efficacy Always at the Price of More Side Effects during Chemotherapy?Docetaxel in the treatment of breast cancer: current experience and future prospects.State of the art of neoadjuvant chemotherapy in breast cancer: rationale, results and recent developments.In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study.Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: a phase II study.
P2860

Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysis.

Item
http://www.wikidata.org/entity/Q44212086
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Dose-dense biweekly doxorubici ...... ncer: second interim analysis.
@en
Dose-dense biweekly doxorubici ...... ncer: second interim analysis.
@nl
type
label
Dose-dense biweekly doxorubici ...... ncer: second interim analysis.
@en
Dose-dense biweekly doxorubici ...... ncer: second interim analysis.
@nl
prefLabel
Dose-dense biweekly doxorubici ...... ncer: second interim analysis.
@en
Dose-dense biweekly doxorubici ...... ncer: second interim analysis.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Dose-dense biweekly doxorubici ...... ncer: second interim analysis.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921